Aseptic filling of parenterals is one of the most challenging tasks within pharmaceutical manufacturing. There is a wide range of challenges from engineer driven tasks like filling accuracy and machine performance to pharmaceutical key questions like how to keep the process sterile while staying compliant with the regulations and guidelines. All of this is influenced by new process methods and innovations in technology and at the same time trying to remain cost effective and make the right decisions quickly.
At the 2019 ISPE Aseptic Conference, you will learn firsthand from people within the industry who are facing these challenges and how they have dealing with them. The sessions, workshops, networking breaks, and social events give you a unique opportunity to discuss the challenges you’re currently facing and gain some actionable ideas and solutions to improve the manufacturing processes at your company.
For the first time, we will have a session for cell and gene therapy! Production systems for this application are challenging for manufacturing operations as the requirements are different from the traditional aseptic fill-finish process. Production limitations may include the culture of modified live cells and very small batch sizes (one patient/batch), as the therapies are highly specialized. In this session, we will cover case-studies from recently completed projects, including lessons learned and an outlook of what’s to come in the future.
An on-going area of interest is disposable equipment and how it is finding its way into the whole production chain and now conquering the last route, the fill/finish path. Sessions include:
I am honored to be the wingman of our chair, Jörg Zimmermann, for the aseptic track for the 6th year in a row and look forward to connecting with you at the 2019 ISPE Aseptic Conference.
To meet the biopharmaceutical industry’s duty to manufacture safe and effective therapies for patients, a robust quality system is fundamental to success. A quality system should link to quality culture and prioritize focusing on quality, led by management, that fosters sustainable compliance and consistent production of high-quality drugs. Strong quality culture attributes include a proactive...
Stability sampling and testing are key to ensuring that products maintain safety, identity, strength, purity, and quality throughout their claimed shelf life. It is also a regulatory requirement per ICH Q5. However, storing product samples in different environmental conditions, testing those samples for three to five years (or more) after initial manufacture, and properly analyzing and...
ISPE hosted more than 450 attendees in person and virtually for the 2024 ISPE Aseptic Conference in Vienna, Austria. Keynotes and education sessions provided a comprehensive overview of key topics and trends...